MPM
BIIB icon

Meritage Portfolio Management’s Biogen BIIB Stock Holding History

Meritage Portfolio Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-677
Closed -$234K – 320
2021
Q2 		$234K Buy
+677
New +$205K 0.01% 279
2020
Q4 		– Sell
-12,563
Closed -$3.56M – 258
2020
Q3 		$3.56M Buy
12,563
+85
+0.7% +$23.7K 0.32% 73
2020
Q2 		$3.34M Sell
12,478
-11,847
-49% -$3.56M 0.32% 83
2020
Q1 		$7.7M Sell
24,325
-696
-3% -$211K 1.04% 22
2019
Q4 		$7.42M Buy
+25,021
New +$6.94M 0.65% 40
2019
Q3 		– Sell
-4,413
Closed -$1.03M – 233
2019
Q2 		$1.03M Sell
4,413
-17,371
-80% -$4.01M 0.11% 145
2019
Q1 		$5.15M Buy
21,784
+4,886
+29% +$1.54M 0.52% 65
2018
Q4 		$5.08M Sell
16,898
-669
-4% -$214K 0.58% 56
2018
Q3 		$6.21M Sell
17,567
-242
-1% -$83.3K 0.57% 59
2018
Q2 		$5.17M Sell
17,809
-730
-4% -$205K 0.5% 84
2018
Q1 		$5.08M Sell
18,539
-136
-0.7% -$42.2K 0.49% 84
2017
Q4 		$5.95M Sell
18,675
-283
-1% -$90.8K 0.57% 69
2017
Q3 		$5.94M Sell
18,958
-9,611
-34% -$2.85M 0.58% 64
2017
Q2 		$7.75M Sell
28,569
-316
-1% -$83.6K 0.8% 23
2017
Q1 		$7.9M Buy
28,885
+12,522
+77% +$3.54M 0.83% 23
2016
Q4 		$4.64M Sell
16,363
-1,064
-6% -$315K 0.51% 103
2016
Q3 		$5.46M Buy
17,427
+15,412
+765% +$4.56M 0.6% 65
2016
Q2 		$487K Buy
2,015
+4
+0.2% +$1.05K 0.05% 161
2016
Q1 		$524K Hold
2,011
– – 0.06% 154
2015
Q4 		$616K Sell
2,011
-18,803
-90% -$5.4M 0.07% 170
2015
Q3 		$6.07M Buy
20,814
+436
+2% +$144K 0.7% 39
2015
Q2 		$8.23M Buy
20,378
+2,203
+12% +$884K 0.86% 13
2015
Q1 		$7.67M Buy
18,175
+233
+1% +$91.8K 0.77% 21
2014
Q4 		$6.09M Buy
17,942
+7,567
+73% +$2.45M 0.65% 42
2014
Q3 		$3.43M Sell
10,375
-262
-2% -$86.4K 0.39% 149
2014
Q2 		$3.35M Buy
+10,637
New +$3.2M 0.37% 157

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Meritage Portfolio Management's BIIB Position: Q3 2021 in Review

Meritage Portfolio Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 677 shares — an estimated $234K sold.

Meritage Portfolio Management first reported a position in BIIB in Q2 2014 and held it in 26 quarters. The position peaked at $8.23M in Q2 2015. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Meritage Portfolio Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Meritage Portfolio Management sold 677 Biogen shares in Q3 2021, an estimated $234K.
  • Meritage Portfolio Management first reported a position in Biogen in Q2 2014 and held it in 26 quarters.
  • Meritage Portfolio Management's Biogen position peaked at $8.23M in Q2 2015.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Meritage Portfolio Management's 13F filing for Q3 2021, filed 26 Oct 2021.